8-K//Current report
Protalix BioTherapeutics, Inc. 8-K
Accession 0001558370-25-011468
$PLXCIK 0001006281operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:58 AM ET
Size
383.9 KB
Accession
0001558370-25-011468
Documents
- 8-Kplx-20250814x8k.htmPrimary
8-K
- EX-99.1plx-20250814xex99d1.htm
EX-99.1
- GRAPHICplx-20250814xex99d1001.jpg
GRAPHIC
- EX-101.SCHplx-20250814.xsd
EX-101.SCH
- EX-101.LABplx-20250814_lab.xml
EX-101.LAB
- EX-101.PREplx-20250814_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-011468-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLplx-20250814x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:58 AM ET
- Size
- 383.9 KB